Search by Drug Name or NDC
NDC 60505-0033-06 PENTOXIFYLLINE 400 mg/1 Details
PENTOXIFYLLINE 400 mg/1
PENTOXIFYLLINE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is PENTOXIFYLLINE.
MedlinePlus Drug Summary
Pentoxifylline is used to improve blood flow in patients with circulation problems to reduce aching, cramping, and tiredness in the hands and feet. It works by decreasing the thickness (viscosity) of blood. This change allows your blood to flow more easily, especially in the small blood vessels of the hands and feet. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 60505-0033-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pentoxifylline
Product Information
| NDC | 60505-0033 |
|---|---|
| Product ID | 60505-0033_f96bc30c-f6a0-8913-979a-c65d53fa7bdc |
| Associated GPIs | 85200010000410 |
| GCN Sequence Number | 006573 |
| GCN Sequence Number Description | pentoxifylline TABLET ER 400 MG ORAL |
| HIC3 | M9S |
| HIC3 Description | HEMORRHEOLOGIC AGENTS |
| GCN | 11800 |
| HICL Sequence Number | 002819 |
| HICL Sequence Number Description | PENTOXIFYLLINE |
| Brand/Generic | Generic |
| Proprietary Name | PENTOXIFYLLINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PENTOXIFYLLINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 400 |
| Active Ingredient Units | mg/1 |
| Substance Name | PENTOXIFYLLINE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075191 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-0033-06 (60505003306)
| NDC Package Code | 60505-0033-6 |
|---|---|
| Billing NDC | 60505003306 |
| Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0033-6) |
| Marketing Start Date | 1999-06-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.27418 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PENTOXIFYLLINE ER 400 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis